Assessment of knowledge on use of Artemether Lumefantrine in management of uncomplicated malaria among outpatients at KIU-TH

dc.contributor.authorKusiima, Jim
dc.date.accessioned2020-07-30T09:49:09Z
dc.date.available2020-07-30T09:49:09Z
dc.date.issued2018-12
dc.descriptionA research report submitted to the school of pharmacy in partial fulfillment for the requirement of the a ward of a Bachelor degree in pharmacy of Kampala International Universityen_US
dc.description.abstractThis study sought to assess the !mow! edge on the use of Artemether/ therapy in the management of uncomplicated malaria among out patients treated at KIU-TI-L A cross sectional study design was employed in this study. Data was collected from August to October 2018 using a questionnaire by simple Random sampling and was entered and analyzed using Microsoft Excel spread sheet and Statistical Package of Social Sciences (SPSS) version 20 respectively. The results were presented in form of tables, charts, graphs and Pearson Chi Square test were generated. The minimum and maximum age of the respondents was 0.5 and 55 respectively given that Skewness was greater than I. (1.043). The findings of the study have demonstrated that the patients' knowledge on use of ArtemetherLumefantrine for management of uncomplicated malaria is inadequate following key parameters of dosing time, duration of treatment, dietary recommendations and response to side effects. Ce1tain aspects which could affect proper use of the drug like knowledge on the possible side effects and what to do when they experience them, the AL dietary requirements and why they should not stop taking their drug even when they feel better before the treatment is over, what to do if they vomited any dose were not clearly understood by the patients. It was found out that patients' level of Education had no significant effect on their knowledge on use of AL. Other patient factors like Marital status, Patient occupation and the frequency of obtaining AL as OTC were not significantly associated with the knowledge expressed by the patients on AL. The major challenges to poor use in this setting were related to difficulties in following expected dosing schedule and most especially the time for the second close, time for completion of the dose, dietary recommendations and what is done when the drug is vomited which could be sorted out through improved counseling and patient Education on taking the medication by the dispenser or pharmacist. CONCLUSION: Patients did not have adequate knowledge on the dispensed drug and particularly on the dosing schedule and dietary recommendations associated with the use of AL. The patients' level of Education did not have a significant effect on the knowledge on use of AL expressed by the patients. This could imply that the quality of patient- service provider interaction and particularly counseling and emphasis on all issues pertaining the use of the dispensed drugs is weak. RECOMMENDATIONS: Re-train health workers particularly dispensers/pharmacists on the purpose of effective counseling on disease and treatment issues of the patients. Ensure that all first doses of AL be administered before the patient leaves the health facility. Set a follow up strategy of the patient to assess response to therapy at least after two days and solve any problems that may have resulted from treatment.en_US
dc.identifier.urihttp://hdl.handle.net/20.500.12306/12483
dc.language.isoenen_US
dc.publisherKampala International University, School of Health Sciences- Western Campusen_US
dc.subjectArtemether Lumefantrineen_US
dc.subjectUncomplicated malariaen_US
dc.subjectOutpatientsen_US
dc.titleAssessment of knowledge on use of Artemether Lumefantrine in management of uncomplicated malaria among outpatients at KIU-THen_US
dc.typeOtheren_US
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
img-0029.pdf
Size:
2.87 MB
Format:
Adobe Portable Document Format
Description:
Full Text
License bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: